Agilent Technologies, Inc. $A Stock Position Lowered by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. decreased its position in Agilent Technologies, Inc. (NYSE:A) by 11.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,295,310 shares of the medical research company’s stock after selling 173,468 shares during the quarter. Balyasny Asset Management L.P. owned about 0.46% of Agilent Technologies worth $152,860,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of A. Resona Asset Management Co. Ltd. boosted its holdings in Agilent Technologies by 6.2% during the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after buying an additional 5,767 shares in the last quarter. TrueMark Investments LLC acquired a new stake in shares of Agilent Technologies during the 2nd quarter valued at $1,999,000. Nuance Investments LLC boosted its stake in shares of Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares in the last quarter. Fenimore Asset Management Inc boosted its stake in shares of Agilent Technologies by 2.7% during the 2nd quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after acquiring an additional 4,823 shares in the last quarter. Finally, Godsey & Gibb Inc. grew its holdings in shares of Agilent Technologies by 19.8% in the 2nd quarter. Godsey & Gibb Inc. now owns 166,664 shares of the medical research company’s stock worth $19,668,000 after acquiring an additional 27,520 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This trade represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 16,401 shares of company stock valued at $2,468,962. 0.26% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A has been the subject of several analyst reports. Robert W. Baird upped their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. JPMorgan Chase & Co. boosted their price objective on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Evercore ISI upped their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $161.77.

Agilent Technologies Price Performance

Shares of A opened at $139.56 on Friday. The business’s 50-day moving average is $145.59 and its 200-day moving average is $129.02. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company has a market capitalization of $39.57 billion, a price-to-earnings ratio of 30.54, a P/E/G ratio of 4.15 and a beta of 1.27. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.32%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.